Subject: CIIX Makes Massive Revenue Jump in Record Fashion

SCV Client Spotlight
BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement., Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence.
Facebook Twitter YouTube
CIIX Makes Massive Revenue Jump in Record Fashion
Hot Stock to WatchHot Stock to Watch

Company:, Inc. (OTCQB: CIIX)


Price: 0.48

Change (%): + 0.00 (0.00)

Volume: 218,401
CIIX Chart, Inc. Announces Record Revenues for Q3 Fiscal Year 2019

Company Reports 81% Year-Over-Year Increase Driven by Continued Demand for its Industrial Hemp/CBD Consumer Product Lines

SAN GABRIEL, California, April 17, 2019 /PRNewswire/ —, Inc. (OTCQB: CIIX) (“CIIX” or “the Company”), an established financial news and investment portal, and a leading industrial hemp retailer for the Chinese-speaking community, today announced its financial and operational summary for the Third Quarter of its Fiscal Year 2019.

“This has been an extremely eventful quarter for us, demonstrated by the successful product launches and initiatives that we have taken to consolidate branding and provide ease and accessibility for our consumers,” said Mr. Warren Wang,, Inc. CEO. “Our financial performance and highlights for the quarter are a testament to the popularity and demand for our CBD and hemp products. As a result, we continue to make significant progress in our business through our investments intended to grow the platform for our consumer product lines. Leading the sales for CBD and hemp products, the Company’s wholly owned foreign entity, CBD Biotechnology Co. Ltd. (“CBD Biotech”), was recently a featured exhibitor at the Vietnam Expo, and introduced our self-branded hemp-infused skincare line and hemp wine, which resulted in an overwhelming reception when our exhibitor inventory sold out within the hour. We have successfully become a key player in the Chinese markets, which is why we are confident the year ahead will be fruitful as we continue expanding our brand recognition for our industrial hemp products beyond China and throughout southeast Asia with the help of our recently appointed CBD Biotech CFO, Alex Hamilton.”

For the first nine months and quarter ended February 28, 2019, cash and cash equivalents for the Company were $2,287,965 and total current assets were $4,487,886. As of February 28, 2019, there were 43,332,692 shares outstanding.

Continue Reading

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks